News

28
May
2024
Rameda Expands Freely Priced Portfolio with Launch of Ramelact, Egypt’s First Lactase Enzyme Supplement for the treatment of Lactose Intolerance
...
20
Mar
2024
Rameda 4Q23 Earnings Release
...
28
Nov
2023
Rameda Maintains its Impressive Momentum with the Launch of a New Type 2 Diabetes Product, Bolstering its Chronic Portfolio
...
14
Nov
2023
Rameda Reports its 3Q23 Results
...
06
Nov
2023
Equinox Pharma Holding Limited (Equinox) increases stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
...
15
Aug
2023
Rameda Reports its 2Q23 Results
...
01
Jun
2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. finalizes acquisition of a portfolio of 11 fast-growing cardiometabolic products
...
15
May
2023
Rameda Reports its 1Q23 Results
...
07
Mar
2023
Rameda Reports its FY22 Results
...
20
Dec
2022
Rameda acquires exclusive rights for the distribution and marketing of “Physiomer” in Egypt
...